For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

University College London

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

γ-H2AX foci formation as a pharmacodynamic marker of DNA damage produced by DNA cross-linking agents: results from 2 phase I clinical trials of SJG-136 (SG2000).

Type
D - Journal article
Title of journal
Clin Cancer Res
Article number
-
Volume number
19
Issue number
3
First page of article
721
ISSN of journal
1078-0432
Year of publication
2013
Number of additional authors
8
Additional information

The author made a substantial contribution to the conception and design of the study, to the organisation of the conduct of the study, to carrying out the study (including acquisition of study data) and to the analysis and interpretation of study data. The author helped draft the output.

Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
0
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-